StockData

Goldenwell Biotech, Inc. (GWLL) stock

GWLLOTCFood and Kindred ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.65+0.05 (+8.33%)

Close on Oct 19, 2026Market cap $64.35MP/E –Yield –

Goldenwell Biotech operating margin

Operating margin is operating income as a percentage of revenue.

Goldenwell Biotech's operating margin for the twelve months ending Jun 30, 2026 was -208729.1%. For fiscal 2025 it was -206047.3%, against -88559.7% the year before. The highest annual figure on record is -740.7% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-206047.3%−117487.6
FY2024Dec 31, 2024-88559.7%−82251.1
FY2023Dec 31, 2023-6308.6%−4247.7
FY2022Dec 31, 2022-2060.9%−1320.2
FY2021Dec 31, 2021-740.7%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2025Dec 31, 2025-41627.3%−31814.2
Q2 FY2024Jun 30, 2024-34402.9%−32039.6
Q4 FY2023Dec 31, 2023-7999.6%−7989.1
Q3 FY2023Sep 30, 2023-9268.6%−8546.8
Q2 FY2023Jun 30, 2023-9813.0%−1403.2
Q1 FY2023Mar 31, 2023-2363.3%−320.2
Q3 FY2022Sep 30, 2022-10.5%+718.7
Q2 FY2022Jun 30, 2022-721.8%–
Q1 FY2022Mar 31, 2022-8409.8%–
Q4 FY2021Dec 31, 2021-2043.1%–
Q3 FY2021Sep 30, 2021-729.2%–

More Goldenwell Biotech figures

See a number that looks wrong?